Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabalin vs. Gabapentin on Reducing Opioid Usage in Trauma Patients

NCT04705480 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.

NCT NCT04705480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabalin vs. Gabapentin on Reducing Opioid Usage in Trauma Patients
Lead sponsor
CAMC Health System
Phase
Phase 4
Overall status
Completed
Start date
April 12, 2021
Completion date
December 13, 2024
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesics, gabapentin, injuries, narcotics, pain, trauma